| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 2.08e-09 | 11 | 110 | 5 | GO:0004143 | |
| GeneOntologyMolecularFunction | complement binding | 8.28e-07 | 32 | 110 | 5 | GO:0001848 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 2.96e-06 | 41 | 110 | 5 | GO:0001727 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 5.60e-06 | 7 | 110 | 3 | GO:0005412 | |
| GeneOntologyMolecularFunction | opsonin binding | 1.01e-05 | 25 | 110 | 4 | GO:0001846 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 1.05e-04 | 17 | 110 | 3 | GO:0005402 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 3.42e-04 | 25 | 110 | 3 | GO:0015149 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 3.42e-04 | 25 | 110 | 3 | GO:0055056 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 4.32e-04 | 27 | 110 | 3 | GO:0015145 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 5.35e-04 | 29 | 110 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 1.31e-03 | 10 | 110 | 2 | GO:0001849 | |
| GeneOntologyBiologicalProcess | lipid phosphorylation | 1.69e-09 | 11 | 109 | 5 | GO:0046834 | |
| GeneOntologyBiologicalProcess | diacylglycerol metabolic process | 3.35e-07 | 28 | 109 | 5 | GO:0046339 | |
| GeneOntologyBiologicalProcess | phosphatidic acid biosynthetic process | 1.24e-06 | 36 | 109 | 5 | GO:0006654 | |
| GeneOntologyBiologicalProcess | phosphatidic acid metabolic process | 2.42e-06 | 41 | 109 | 5 | GO:0046473 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 1.91e-05 | 62 | 109 | 5 | GO:0002455 | |
| GeneOntologyBiologicalProcess | complement activation | 3.46e-05 | 70 | 109 | 5 | GO:0006956 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 8.51e-05 | 44 | 109 | 4 | GO:0006958 | |
| HumanPheno | Reduced circulating complement concentration | 3.47e-05 | 58 | 34 | 5 | HP:0004431 | |
| HumanPheno | Abnormality of complement system | 4.44e-05 | 61 | 34 | 5 | HP:0005339 | |
| Domain | DAGK_acc | 1.45e-09 | 10 | 108 | 5 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 1.45e-09 | 10 | 108 | 5 | IPR000756 | |
| Domain | DAGKa | 1.45e-09 | 10 | 108 | 5 | SM00045 | |
| Domain | DAGKc | 1.13e-08 | 14 | 108 | 5 | SM00046 | |
| Domain | Diacylglycerol_kinase_cat_dom | 1.69e-08 | 15 | 108 | 5 | IPR001206 | |
| Domain | DAGK | 1.69e-08 | 15 | 108 | 5 | PS50146 | |
| Domain | DAGK_cat | 1.69e-08 | 15 | 108 | 5 | PF00781 | |
| Domain | NAD/diacylglycerol_kinase | 3.45e-08 | 17 | 108 | 5 | IPR016064 | |
| Domain | - | 1.43e-07 | 22 | 108 | 5 | 2.130.10.30 | |
| Domain | RCC1/BLIP-II | 1.82e-07 | 23 | 108 | 5 | IPR009091 | |
| Domain | RCC1 | 4.77e-06 | 20 | 108 | 4 | PF00415 | |
| Domain | RCC1_1 | 5.87e-06 | 21 | 108 | 4 | PS00625 | |
| Domain | RCC1_2 | 5.87e-06 | 21 | 108 | 4 | PS00626 | |
| Domain | RCC1_3 | 5.87e-06 | 21 | 108 | 4 | PS50012 | |
| Domain | Reg_chr_condens | 7.14e-06 | 22 | 108 | 4 | IPR000408 | |
| Domain | Na/solute_symporter_CS | 1.03e-05 | 8 | 108 | 3 | IPR018212 | |
| Domain | HECT | 1.67e-05 | 27 | 108 | 4 | PF00632 | |
| Domain | HECTc | 1.67e-05 | 27 | 108 | 4 | SM00119 | |
| Domain | HECT_dom | 1.67e-05 | 27 | 108 | 4 | IPR000569 | |
| Domain | HECT | 1.67e-05 | 27 | 108 | 4 | PS50237 | |
| Domain | C1_1 | 1.94e-05 | 57 | 108 | 5 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 3.42e-05 | 64 | 108 | 5 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 3.42e-05 | 64 | 108 | 5 | PS50081 | |
| Domain | C1 | 3.69e-05 | 65 | 108 | 5 | SM00109 | |
| Domain | PE/DAG-bd | 3.98e-05 | 66 | 108 | 5 | IPR002219 | |
| Domain | SSF | 3.98e-05 | 12 | 108 | 3 | PF00474 | |
| Domain | NA_SOLUT_SYMP_2 | 3.98e-05 | 12 | 108 | 3 | PS00457 | |
| Domain | Na/solute_symporter | 3.98e-05 | 12 | 108 | 3 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 3.98e-05 | 12 | 108 | 3 | PS50283 | |
| Domain | Ago_hook | 9.90e-05 | 3 | 108 | 2 | PF10427 | |
| Domain | TNRC6_PABC-bd | 9.90e-05 | 3 | 108 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 9.90e-05 | 3 | 108 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 9.90e-05 | 3 | 108 | 2 | PF16608 | |
| Domain | MAM | 1.44e-04 | 18 | 108 | 3 | PF00629 | |
| Domain | MAM_dom | 1.44e-04 | 18 | 108 | 3 | IPR000998 | |
| Domain | MAM_2 | 1.44e-04 | 18 | 108 | 3 | PS50060 | |
| Domain | Anaphylatoxin_comp_syst | 3.28e-04 | 5 | 108 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 3.28e-04 | 5 | 108 | 2 | IPR001840 | |
| Domain | ANATO | 6.83e-04 | 7 | 108 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 6.83e-04 | 7 | 108 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 6.83e-04 | 7 | 108 | 2 | PS01177 | |
| Domain | ANATO | 6.83e-04 | 7 | 108 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 6.83e-04 | 7 | 108 | 2 | IPR000020 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 9.07e-04 | 8 | 108 | 2 | IPR019565 | |
| Domain | Thiol-ester_cl | 9.07e-04 | 8 | 108 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 9.07e-04 | 8 | 108 | 2 | IPR019742 | |
| Domain | A2M | 1.45e-03 | 10 | 108 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.45e-03 | 10 | 108 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.45e-03 | 10 | 108 | 2 | IPR011626 | |
| Domain | A2M_recep | 1.45e-03 | 10 | 108 | 2 | PF07677 | |
| Domain | A2M_comp | 1.45e-03 | 10 | 108 | 2 | PF07678 | |
| Domain | A2M_N | 1.45e-03 | 10 | 108 | 2 | PF01835 | |
| Domain | A2M_N | 1.45e-03 | 10 | 108 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.45e-03 | 10 | 108 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.45e-03 | 10 | 108 | 2 | PS00477 | |
| Domain | A2M_N_2 | 1.45e-03 | 10 | 108 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 1.45e-03 | 10 | 108 | 2 | IPR001599 | |
| Domain | NA_SOLUT_SYMP_1 | 1.76e-03 | 11 | 108 | 2 | PS00456 | |
| Domain | - | 2.38e-03 | 46 | 108 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 2.69e-03 | 48 | 108 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.86e-03 | 49 | 108 | 3 | IPR002172 | |
| Domain | LDLa | 2.86e-03 | 49 | 108 | 3 | SM00192 | |
| Domain | LDLRA_2 | 2.86e-03 | 49 | 108 | 3 | PS50068 | |
| Domain | PP2C_SIG | 2.88e-03 | 14 | 108 | 2 | SM00331 | |
| Domain | PPM_1 | 3.31e-03 | 15 | 108 | 2 | PS01032 | |
| Domain | MAM_1 | 3.77e-03 | 16 | 108 | 2 | PS00740 | |
| Domain | PP2C | 4.26e-03 | 17 | 108 | 2 | IPR015655 | |
| Domain | MAM | 4.26e-03 | 17 | 108 | 2 | SM00137 | |
| Domain | Propept_inh | 4.26e-03 | 17 | 108 | 2 | IPR009020 | |
| Domain | C345C | 4.26e-03 | 17 | 108 | 2 | SM00643 | |
| Domain | CUB_dom | 4.39e-03 | 57 | 108 | 3 | IPR000859 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 4.77e-03 | 18 | 108 | 2 | IPR008930 | |
| Domain | Zn_pept | 4.77e-03 | 18 | 108 | 2 | SM00631 | |
| Domain | PP2C | 5.31e-03 | 19 | 108 | 2 | PF00481 | |
| Domain | NTR | 5.31e-03 | 19 | 108 | 2 | PF01759 | |
| Domain | Fibrinogen_CS | 5.31e-03 | 19 | 108 | 2 | IPR020837 | |
| Domain | Netrin_module_non-TIMP | 5.31e-03 | 19 | 108 | 2 | IPR018933 | |
| Domain | CARBOXYPEPT_ZN_2 | 5.31e-03 | 19 | 108 | 2 | PS00133 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 2.68e-07 | 25 | 81 | 5 | MM14511 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 3.24e-07 | 11 | 81 | 4 | M47874 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 4.04e-07 | 27 | 81 | 5 | M12123 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 6.95e-07 | 13 | 81 | 4 | M4732 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 4.57e-06 | 20 | 81 | 4 | M917 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 6.84e-06 | 22 | 81 | 4 | M39502 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 2.92e-05 | 11 | 81 | 3 | MM1430 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 3.22e-05 | 106 | 81 | 6 | M42535 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 7.91e-05 | 15 | 81 | 3 | M7146 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 1.17e-04 | 17 | 81 | 3 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 1.17e-04 | 17 | 81 | 3 | MM1369 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 1.66e-04 | 19 | 81 | 3 | MM14718 | |
| Pathway | KEGG_GLYCEROLIPID_METABOLISM | 1.76e-04 | 49 | 81 | 4 | M15902 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 2.26e-04 | 21 | 81 | 3 | M27058 | |
| Pathway | WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN | 3.22e-04 | 5 | 81 | 2 | M48329 | |
| Pathway | REACTOME_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE | 3.22e-04 | 5 | 81 | 2 | M27204 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 4.82e-04 | 6 | 81 | 2 | MM15083 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 5.18e-04 | 115 | 81 | 5 | M19752 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 6.59e-04 | 69 | 81 | 4 | M16894 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 6.72e-04 | 7 | 81 | 2 | MM14685 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 6.72e-04 | 7 | 81 | 2 | M46421 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 8.93e-04 | 8 | 81 | 2 | M27031 | |
| Pathway | REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION | 8.93e-04 | 8 | 81 | 2 | M27005 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 8.93e-04 | 8 | 81 | 2 | M47872 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_PROTHROMBIN_TO_THROMBIN | 8.93e-04 | 8 | 81 | 2 | M47784 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 9.48e-04 | 76 | 81 | 4 | M9052 | |
| Pathway | KEGG_GLYCEROPHOSPHOLIPID_METABOLISM | 9.96e-04 | 77 | 81 | 4 | M9131 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 1.14e-03 | 9 | 81 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 1.14e-03 | 9 | 81 | 2 | M46436 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 1.15e-03 | 80 | 81 | 4 | M6121 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.38e-03 | 84 | 81 | 4 | MM14653 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 1.42e-03 | 10 | 81 | 2 | M48013 | |
| Pathway | WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY | 2.07e-03 | 12 | 81 | 2 | M48316 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 2.07e-03 | 12 | 81 | 2 | MM1368 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 2.44e-03 | 13 | 81 | 2 | M46434 | |
| Pubmed | 1.44e-10 | 11 | 112 | 5 | 17021016 | ||
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 24868011 | ||
| Pubmed | 3.25e-08 | 3 | 112 | 3 | 10833454 | ||
| Pubmed | 1.30e-07 | 4 | 112 | 3 | 21502512 | ||
| Pubmed | Functional analysis of Ficolin-3 mediated complement activation. | 1.30e-07 | 4 | 112 | 3 | 21085669 | |
| Pubmed | Collectin-11 detects stress-induced L-fucose pattern to trigger renal epithelial injury. | 1.30e-07 | 4 | 112 | 3 | 27088797 | |
| Pubmed | Toward a structure-based comprehension of the lectin pathway of complement. | 3.24e-07 | 5 | 112 | 3 | 23911397 | |
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 20038603 | ||
| Pubmed | 3.24e-07 | 5 | 112 | 3 | 9382884 | ||
| Pubmed | 1.13e-06 | 7 | 112 | 3 | 22792067 | ||
| Pubmed | 1.80e-06 | 8 | 112 | 3 | 24474777 | ||
| Pubmed | 7.00e-06 | 12 | 112 | 3 | 18524992 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 1.03e-05 | 2 | 112 | 2 | 16565498 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 15998580 | ||
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 1.03e-05 | 2 | 112 | 2 | 7373044 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 19062096 | ||
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 1.03e-05 | 2 | 112 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 1.03e-05 | 2 | 112 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 1.03e-05 | 2 | 112 | 2 | 16098595 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 1.03e-05 | 2 | 112 | 2 | 19933335 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 17548659 | ||
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 1.03e-05 | 2 | 112 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 1.03e-05 | 2 | 112 | 2 | 17645767 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 29791863 | ||
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 1.03e-05 | 2 | 112 | 2 | 15787745 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12207352 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 30026462 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 6559257 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 1.03e-05 | 2 | 112 | 2 | 27758680 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 22387014 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 1.03e-05 | 2 | 112 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 1.03e-05 | 2 | 112 | 2 | 20506482 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 36574978 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12480675 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 26800705 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 1.03e-05 | 2 | 112 | 2 | 23749435 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 23918728 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 1.03e-05 | 2 | 112 | 2 | 15390104 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 1.03e-05 | 2 | 112 | 2 | 3037333 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 22071314 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 11726230 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 4216347 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 1.03e-05 | 2 | 112 | 2 | 1699796 | |
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 1.03e-05 | 2 | 112 | 2 | 6950384 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 1.03e-05 | 2 | 112 | 2 | 2997024 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 21194521 | ||
| Pubmed | No association of TDP-43 with sporadic frontotemporal dementia. | 1.03e-05 | 2 | 112 | 2 | 17614162 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 8660986 | ||
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 1.03e-05 | 2 | 112 | 2 | 3624865 | |
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 1.03e-05 | 2 | 112 | 2 | 8428773 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 21857912 | ||
| Pubmed | A novel assay to quantitate MASP-2/ficolin-3 complexes in serum. | 1.03e-05 | 2 | 112 | 2 | 23142462 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 24638111 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 1.03e-05 | 2 | 112 | 2 | 4514997 | |
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 1.03e-05 | 2 | 112 | 2 | 21345967 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 1.03e-05 | 2 | 112 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 1.03e-05 | 2 | 112 | 2 | 3167981 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 7545960 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 30041577 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 21403131 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 2572548 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 2302180 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 1.03e-05 | 2 | 112 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 1.03e-05 | 2 | 112 | 2 | 34358307 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 1.03e-05 | 2 | 112 | 2 | 18360261 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 1.03e-05 | 2 | 112 | 2 | 18091514 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 29080553 | ||
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 1.03e-05 | 2 | 112 | 2 | 26814963 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 1.03e-05 | 2 | 112 | 2 | 25339671 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 17728371 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 6149580 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 6149581 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12115608 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 3542363 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 2387317 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 8132550 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 2395880 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 26814708 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 6192448 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 6167582 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 16908004 | ||
| Pubmed | Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. | 1.03e-05 | 2 | 112 | 2 | 1438267 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 7365238 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 19150565 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 7391573 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 17506029 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 17971360 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 23715124 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 3464002 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 2993295 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 1.03e-05 | 2 | 112 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 1.03e-05 | 2 | 112 | 2 | 17971229 | |
| Pubmed | Inhibition of neutrophil elastase suppresses the development of skin tumors in hairless mice. | 1.03e-05 | 2 | 112 | 2 | 8757756 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 6881182 | ||
| Pubmed | Identification of the site of sulfation of the fourth component of human complement. | 1.03e-05 | 2 | 112 | 2 | 3944109 | |
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 1.03e-05 | 2 | 112 | 2 | 17921792 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 3.25e-10 | 10 | 78 | 5 | 1178 | |
| GeneFamily | Complement system|Sushi domain containing | 1.70e-05 | 36 | 78 | 4 | 492 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 6.49e-04 | 9 | 78 | 2 | 1234 | |
| GeneFamily | Protein phosphatases, Mg2+/Mn2+ dependent | 2.40e-03 | 17 | 78 | 2 | 701 | |
| GeneFamily | Carboxypeptidases | 3.66e-03 | 21 | 78 | 2 | 1321 | |
| GeneFamily | Ankyrin repeat domain containing | 3.94e-03 | 242 | 78 | 5 | 403 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 4.66e-03 | 78 | 78 | 3 | 262 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 5.17e-03 | 25 | 78 | 2 | 775 | |
| GeneFamily | Fibrinogen C domain containing | 5.17e-03 | 25 | 78 | 2 | 554 | |
| GeneFamily | WD repeat domain containing | 5.50e-03 | 262 | 78 | 5 | 362 | |
| GeneFamily | Sterile alpha motif domain containing | 6.52e-03 | 88 | 78 | 3 | 760 | |
| GeneFamily | WD repeat domain containing|Caspase recruitment domain containing|Apoptosome | 7.39e-03 | 30 | 78 | 2 | 959 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.80e-07 | 187 | 112 | 7 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | Tuft-tuft-1|World / Class top | 4.27e-06 | 168 | 112 | 6 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-06 | 180 | 112 | 6 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-06 | 192 | 112 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 199 | 112 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| Drug | AC1L4Q08 | 7.01e-07 | 15 | 111 | 4 | CID000161747 | |
| Drug | 1-stearoyl-2-arachidonoyl-sn-glycerol | 1.44e-06 | 40 | 111 | 5 | CID000001398 | |
| Drug | 1,2-dicaprin | 4.04e-06 | 49 | 111 | 5 | CID000001321 | |
| Drug | diradylglycerol | 4.94e-06 | 51 | 111 | 5 | CID006437874 | |
| Drug | 1,3-DCG | 6.73e-06 | 94 | 111 | 6 | CID000150911 | |
| Drug | DiC8 | 7.51e-06 | 146 | 111 | 7 | CID000001323 | |
| Drug | octylglucopyranoside | 1.54e-05 | 163 | 111 | 7 | CID000062080 | |
| Drug | R59949 | 2.37e-05 | 70 | 111 | 5 | CID000657356 | |
| Disease | Complement deficiency disease | 1.31e-07 | 33 | 108 | 5 | C0272242 | |
| Disease | Antibody Deficiency Syndrome | 3.12e-05 | 17 | 108 | 3 | C0003257 | |
| Disease | response to cranial radiation therapy, short-term memory | 7.07e-05 | 60 | 108 | 4 | EFO_0004335, EFO_0010950 | |
| Disease | Immunologic Deficiency Syndromes | 8.01e-05 | 23 | 108 | 3 | C0021051 | |
| Disease | brain measurement, hippocampal volume | 1.97e-04 | 6 | 108 | 2 | EFO_0004464, EFO_0005035 | |
| Disease | Large cell carcinoma of lung | 2.19e-04 | 32 | 108 | 3 | C0345958 | |
| Disease | X-21448 measurement | 5.86e-04 | 10 | 108 | 2 | EFO_0800816 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 7.14e-04 | 11 | 108 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | gamma-glutamylleucine measurement | 1.01e-03 | 13 | 108 | 2 | EFO_0021140 | |
| Disease | triacylglycerol 46:2 measurement | 1.17e-03 | 14 | 108 | 2 | EFO_0010402 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 1.54e-03 | 62 | 108 | 3 | DOID:9074 (is_implicated_in) | |
| Disease | brain infarction | 1.95e-03 | 18 | 108 | 2 | EFO_0004277 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 2.12e-03 | 147 | 108 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | blood metabolite measurement | 2.18e-03 | 19 | 108 | 2 | EFO_0005664 | |
| Disease | Lupus Erythematosus, Systemic | 2.27e-03 | 71 | 108 | 3 | C0024141 | |
| Disease | lean body mass | 2.75e-03 | 379 | 108 | 6 | EFO_0004995 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLSGGTWTQAGQGQL | 211 | Q14146 | |
| EVQTGFGRLGSHFWG | 321 | Q9BYV1 | |
| VFAAAAAGTQGWQGL | 671 | Q9Y2J4 | |
| LEARDGHSQLGGWNG | 361 | P51689 | |
| QLNTATWGNLTGLGG | 231 | O95319 | |
| GSSGWSGGLAQNRST | 426 | P07357 | |
| AAWLTRQGSFQGGFR | 1286 | P0C0L5 | |
| NAVGTSSGWNRIGTG | 46 | P86434 | |
| QAGRQALAAARGSWG | 1251 | Q96L96 | |
| GGGSRLNSGNRWFDK | 311 | P43155 | |
| GSWRVGQTAGGSRNF | 521 | Q9HC96 | |
| EFNSGLLHWQLGGGD | 1881 | Q8NFD5 | |
| HSGIWSFEGIGGNQD | 2456 | O75179 | |
| SGDATWGLRLVGGSN | 576 | Q9NR16 | |
| RGNGAGIVWFTTDSG | 221 | Q6UXS9 | |
| GGGNGSKNWSEDDLQ | 446 | Q99543 | |
| GGSWALAGNQAIGEL | 1221 | Q5H9R4 | |
| NQASEGSWAGAGAGN | 1271 | Q5H9R4 | |
| WANSGDQISGGFLVG | 1426 | Q5H9R4 | |
| GFLVGIVDQANGGSW | 1436 | Q5H9R4 | |
| LAVSADGGLFGWGNS | 296 | Q96I51 | |
| LLLDAAGQVFSWGGG | 171 | A6NED2 | |
| WGGNNGSTLTAAVLA | 66 | Q9NPH2 | |
| ARQGASAGTEWGAGA | 111 | Q96PH1 | |
| GRNSGPNRAQGSWAT | 1826 | O60840 | |
| EGGGWLVFQRRQDGS | 126 | O75636 | |
| ANTLIGNWDRSFGGG | 316 | O75439 | |
| GNWDRSFGGGMNLSS | 321 | O75439 | |
| LGTGNDLARVLGWGA | 576 | Q5KSL6 | |
| WQNGGARGAFAKDLG | 131 | O75593 | |
| RGLIRTGGWFDGTQQ | 456 | Q09327 | |
| DRGQLFSWGAGSDGQ | 101 | Q15034 | |
| GLSGLLNASGGSWRE | 26 | Q8N5H3 | |
| IGVDLNRNWKSGFGG | 266 | Q8WXQ8 | |
| LQGNLWGTEALGALG | 881 | O43593 | |
| GPGATGQAAANWTAG | 231 | Q9NS67 | |
| GQAAANWTAGFGRGP | 236 | Q9NS67 | |
| TLSGAIFGWGRNKFG | 206 | Q5GLZ8 | |
| IFGWGRNKFGQLGLN | 211 | Q5GLZ8 | |
| ASGGLRFGASAAQGW | 61 | Q8N819 | |
| FSNNGGQWLVSGGDD | 61 | Q96JK2 | |
| GINQGQRSSGGGDHW | 156 | P57055 | |
| LSTAQGAISRGLGGW | 546 | Q8N3D4 | |
| IARDVAGATWGNGSG | 311 | P36915 | |
| RIGNGKFSLSGGNWD | 636 | Q9UK32 | |
| GGLDASGANLWASAN | 41 | Q96KJ4 | |
| WNRGQTGANGGRKFL | 86 | Q96PQ7 | |
| LWARTGGGGEAAAYN | 361 | Q9P2V4 | |
| ATGFGQGNIRALWQS | 346 | Q96IR7 | |
| LQWLGSGAQGAVFLG | 171 | O43283 | |
| DSNTFRWGLGNGISI | 1111 | Q5VYJ5 | |
| LSNGSNGWFRFILDG | 686 | Q9ULT8 | |
| GFGDGFWRQRDLDSN | 596 | Q8TE85 | |
| QRQGGWSTDGGGRLL | 366 | Q5SW24 | |
| AEGAGYNGWTSGRQN | 301 | Q66K79 | |
| NLSWTGNRGFISVAG | 351 | Q9UKA2 | |
| LGTGNDLARTLNWGG | 461 | O75912 | |
| GGGSDLRLWTVNGDL | 3681 | Q99698 | |
| GATGQAAANWIAGFG | 236 | Q9NS66 | |
| DIGTASGWGLTQRGF | 566 | O00187 | |
| LGTGNDLARVLGWGS | 406 | Q16760 | |
| SGQAAANWLAGFGRG | 236 | P60893 | |
| KTLGFNLESGWGSGR | 176 | Q14527 | |
| GTGNDLSNTLGWGTG | 311 | P52429 | |
| GTGNDLARTLNWGGG | 381 | Q13574 | |
| SGEGFNVNVAWAGGL | 751 | Q8WUI4 | |
| RGSSFLAGEASWLNG | 411 | Q9UKT8 | |
| GWATSAPGNARFGQG | 646 | Q9UGM3 | |
| GWATSAPGNARFGQG | 906 | Q9UGM3 | |
| WATSAPGNARFGQGS | 1296 | Q9UGM3 | |
| WGLPFLNGTEANGTG | 86 | Q4U2R8 | |
| GLWLSLGGFHERGQD | 121 | Q86X76 | |
| RAGAQAAGSTWLQGF | 26 | Q5VZR4 | |
| RAGAQAAGSTWLQGF | 26 | Q5SR56 | |
| SAWLTRQGSFQGGFR | 1286 | P0C0L4 | |
| WPLLGSAQGQFSAGG | 21 | Q15262 | |
| RGGEGLLSSQHQWQF | 926 | Q9BVI0 | |
| GAGGQFLSGQEWYRQ | 671 | Q9NZ71 | |
| NTGRSQGGWSYRDGN | 101 | Q8NHS9 | |
| GSNSGAAIGWGSASN | 376 | Q13148 | |
| EDLAGAVGGLGWNSR | 56 | Q96MH2 | |
| GGFISFNGSWRVQGI | 246 | Q5SGD2 | |
| LEPSGNGGEGTRSQW | 6 | O14508 | |
| DGWLQGQNSRGETGL | 36 | Q8WV41 | |
| QEGGFRSLWRGNGIN | 141 | Q8N5S1 | |
| AAGGLAVGGFEWNAT | 101 | Q2M3M2 | |
| GEQGQPWGRFGAALT | 511 | P11215 | |
| NFFRAWNGGFSGNLE | 161 | Q9BRX8 | |
| WNGGFSGNLEGEGFI | 166 | Q9BRX8 | |
| GVRALSLGGQVWGNF | 421 | Q7L0J3 | |
| GGVAWQAGLRTGDFL | 671 | Q9UPX8 | |
| AAGGGGGWNDNTSLL | 876 | Q9UM73 | |
| LQLGNGAGNRFWAAN | 606 | Q96P48 | |
| QWRANPSRGGGGVSF | 16 | P49842 | |
| VGQRWEQGRSFGSLA | 306 | A2A3L6 | |
| LNWQGGGGDAASSQE | 701 | Q7Z392 | |
| LQFLGFWGNRVGDEG | 901 | Q9HC29 | |
| GGEASLQGCRWGANG | 206 | Q9ULX5 | |
| GGGWIVFQRRNTGQL | 1106 | Q9UQP3 | |
| RANEQGAFWGLIAGL | 466 | A0PJK1 | |
| SGDWIAFGCSGLGQL | 341 | Q15269 | |
| GAGNNWAKGRYTEGA | 96 | A6NNZ2 | |
| LAQGGSAGWGALLFT | 166 | Q8N661 | |
| GGGAQDARGLFWVLD | 1026 | Q8IUG5 | |
| ARNGAGPEWGGFEEN | 11 | Q9GZM5 | |
| GNRWGGCADNLSYGL | 151 | O96014 | |
| LGWGSEAAGFQESRG | 76 | Q9BSN7 | |
| SQQLGRRGQWALGEG | 51 | Q9Y2Y4 | |
| GGRSGSNWGRGSNMN | 1306 | Q9C0J8 | |
| GAASGIAIGGFEWNA | 91 | P13866 | |
| SAGAQDRIGWAFGLG | 301 | O95363 | |
| WNAAQGGTAGSLRQR | 1091 | Q9NVE5 | |
| GWVAGNLSARGDGAA | 836 | Q04912 | |
| NTNKGGGVWESGAAN | 566 | Q8NDV7 | |
| QQLGIQGLGLDSGSW | 11 | Q9UDV7 | |
| SAGSGDDFDQGDNGW | 276 | O15321 | |
| GQNEIGTWGNGGNAS | 776 | Q9UPQ9 | |
| GRLAGNTLGSRWSSG | 121 | O95071 | |
| ALAQQWRGTSSGFGR | 931 | Q5TIE3 | |
| AQVQAGAGWGGLEAA | 51 | Q86VY4 | |
| GAGWGGLEAAASAQL | 56 | Q86VY4 | |
| SFGGRNQGGSSWEAP | 121 | Q5BKZ1 | |
| CARNWSRGAAGGDGQ | 191 | B1AL88 | |
| RQGKGSIFVWASGNG | 296 | P29120 | |
| SIFVWASGNGGRQGD | 301 | P29120 |